Parathyroid Clinical Trials

70 recruitingLast updated: July 25, 2026

There are 70 actively recruiting parathyroid clinical trials across 34 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4, Phase 1, Early Phase 1. Top locations include Paris, France, Bethesda, Maryland, United States, Besançon, France. Updated daily from ClinicalTrials.gov.


Parathyroid Trials at a Glance

70 actively recruiting trials for parathyroid are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Paris, Bethesda, and Besançon. Lead sponsors running parathyroid studies include Ascendis Pharma A/S, Peking Union Medical College Hospital, and Shaanxi Micot Pharmaceutical Technology Co., Ltd..

Browse parathyroid trials by phase

Treatments under study

About Parathyroid Clinical Trials

Looking for clinical trials for Parathyroid? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Parathyroid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Parathyroid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 70 trials

Recruiting
Phase 3

A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism

Hypoparathyroidism
Ascendis Pharma A/S12 enrolled1 locationNCT07706764
Recruiting
Phase 3

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Hypoparathyroidism
MBX Biosciences160 enrolled2 locationsNCT07699471
Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Endocrine TumorsNeuroblastomaThyroid Neoplasms+2 more
National Cancer Institute (NCI)2,415 enrolled1 locationNCT01005654
Recruiting
Not Applicable

Parathyroidectomy After Kidney Transplantation

HyperparathyroidismKidney Transplantation Recipients
Aarhus University Hospital85 enrolled1 locationNCT07415421
Recruiting

Natural History Study of Parathyroid Disorders

Multiple Endocrine Neoplasia Type 1Primary HyperparathyroidismParathyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3,000 enrolled1 locationNCT04969926
Recruiting
Phase 2Phase 3

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

Parathyroid Adenoma
Andrei Iagaru100 enrolled1 locationNCT05891769
Recruiting
Phase 4

The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response

surgical stress responseThyroid CancerThyroid and Parathyroid Surgery+1 more
University Hospital Dubrava48 enrolled1 locationNCT07600580
Recruiting

Precision Medicine Approaches to Renal Osteodystrophy

Chronic Kidney DiseasesCkd-MbdSecondary Hyperparathyroidism+2 more
Thomas Nickolas40 enrolled1 locationNCT05880914
Recruiting
Not Applicable

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Hyperparathyroidism, Primary
University of Pennsylvania76 enrolled1 locationNCT06562881
Recruiting
Phase 2Phase 3

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)193 enrolled1 locationNCT07444723
Recruiting

Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet

Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon20 enrolled7 locationsNCT07007338
Recruiting

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Primary HyperparathyroidismParathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma+1 more
M.D. Anderson Cancer Center310 enrolled1 locationNCT03039439
Recruiting
Early Phase 1

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

Hypoparathyroidism
Peking Union Medical College Hospital6 enrolled1 locationNCT07197450
Recruiting
Phase 2

A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

Hypoparathyroidism
Peking Union Medical College Hospital60 enrolled1 locationNCT07540286
Recruiting

Parathyroid Tumor Clonal Status

Primary HyperparathyroidismParathyroid TumorSecondary Hyperparathyroidism (SHPT)+1 more
Washington University School of Medicine839 enrolled1 locationNCT05997810
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting

Risk Factors for Hypoparathyroidism Following Thyroidectomy

Post-Surgical Hypoparathyroidism
Tartu University Hospital300 enrolled2 locationsNCT07582562
Recruiting
Not Applicable

Calcium Replacement Therapy in Postoperative Hypoparathyroidism

Post-Thyroidectomy Hypoparathyroidism Treatment
Tartu University Hospital50 enrolled2 locationsNCT07577570
Recruiting
Phase 3

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma Bone Diseases A/S36 enrolled3 locationsNCT07081997
Recruiting

Parathyroid Assessment of Symptoms French Version

Quality of Life in Primary Hyperparathyroidism
Nantes University Hospital548 enrolled1 locationNCT06450431